Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 19

1.

Comparison Between Urinalysis Results and Self-Reported Heroin Use Among Patients Undergoing Methadone Maintenance Treatment in China.

Li L, Liang LJ, Lin C, Feng N, Wu Z.

Subst Use Misuse. 2017 Aug 24;52(10):1307-1314. doi: 10.1080/10826084.2016.1276598. Epub 2017 Mar 27.

2.

Behavioral factors predicting response to employment-based reinforcement of cocaine abstinence in methadone patients.

Holtyn AF, Washington WD, Knealing TW, Wong CJ, Kolodner K, Silverman K.

Transl Issues Psychol Sci. 2016 Jun;2(2):192-202.

3.

Improvements in health-related quality of life among methadone maintenance clients in Dar es Salaam, Tanzania.

Ubuguyu O, Tran OC, Bruce RD, Masao F, Nyandindi C, Sabuni N, McCurdy S, Mbwambo J, Lambdin BH.

Int J Drug Policy. 2016 Apr;30:74-81. doi: 10.1016/j.drugpo.2016.03.005. Epub 2016 Mar 11.

4.

Comparisons of Cocaine-Only, Opioid-Only, and Users of Both Substances in the National Epidemiologic Survey on Alcohol and Related Conditions (NESARC).

Leeman RF, Sun Q, Bogart D, Beseler CL, Sofuoglu M.

Subst Use Misuse. 2016;51(5):553-64. doi: 10.3109/10826084.2015.1122063. Epub 2016 Mar 22.

5.

Exercise decreases speedball self-administration.

Lacy RT, Strickland JC, Brophy MK, Witte MA, Smith MA.

Life Sci. 2014 Oct 2;114(2):86-92. doi: 10.1016/j.lfs.2014.08.005. Epub 2014 Aug 14.

6.

The therapeutic workplace to promote treatment engagement and drug abstinence in out-of-treatment injection drug users: a randomized controlled trial.

Holtyn AF, Koffarnus MN, DeFulio A, Sigurdsson SO, Strain EC, Schwartz RP, Leoutsakos JM, Silverman K.

Prev Med. 2014 Nov;68:62-70. doi: 10.1016/j.ypmed.2014.02.021. Epub 2014 Mar 4.

7.

Pharmacogenetic randomized trial for cocaine abuse: disulfiram and α1A-adrenoceptor gene variation.

Shorter D, Nielsen DA, Huang W, Harding MJ, Hamon SC, Kosten TR.

Eur Neuropsychopharmacol. 2013 Nov;23(11):1401-7. doi: 10.1016/j.euroneuro.2013.05.014. Epub 2013 Jul 10.

8.

Prevalence of mood and substance use disorders among patients seeking primary care office-based buprenorphine/naloxone treatment.

Savant JD, Barry DT, Cutter CJ, Joy MT, Dinh A, Schottenfeld RS, Fiellin DA.

Drug Alcohol Depend. 2013 Jan 1;127(1-3):243-7. doi: 10.1016/j.drugalcdep.2012.06.020. Epub 2012 Jul 6.

9.

Superior methadone treatment outcome in Hmong compared with non-Hmong patients.

Bart G, Wang Q, Hodges JS, Nolan C, Carlson G.

J Subst Abuse Treat. 2012 Oct;43(3):269-75. doi: 10.1016/j.jsat.2011.12.006. Epub 2012 Jan 28.

10.

The impact of cocaine use on outcomes in HIV-infected patients receiving buprenorphine/naloxone.

Sullivan LE, Botsko M, Cunningham CO, O'Connor PG, Hersh D, Mitty J, Lum PJ, Schottenfeld RS, Fiellin DA; BHIVES Collaborative.

J Acquir Immune Defic Syndr. 2011 Mar 1;56 Suppl 1:S54-61. doi: 10.1097/QAI.0b013e3182097576.

11.

Injection risk behaviors among rural drug users: implications for HIV prevention.

Havens JR, Oser CB, Leukefeld CG.

AIDS Care. 2011 May;23(5):638-45. doi: 10.1080/09540121.2010.516346.

12.
13.

The association between cocaine use and treatment outcomes in patients receiving office-based buprenorphine/naloxone for the treatment of opioid dependence.

Sullivan LE, Moore BA, O'Connor PG, Barry DT, Chawarski MC, Schottenfeld RS, Fiellin DA.

Am J Addict. 2010 Jan-Feb;19(1):53-8. doi: 10.1111/j.1521-0391.2009.00003.x.

14.
15.

Correlates of stimulant treatment outcome across treatment modalities.

Peirce JM, Petry NM, Roll JM, Kolodner K, Krasnansky J, Stabile PQ, Brown C, Stitzer ML.

Am J Drug Alcohol Abuse. 2009;35(1):48-53. doi: 10.1080/00952990802455444.

16.

The North American Opiate Medication Initiative (NAOMI): profile of participants in North America's first trial of heroin-assisted treatment.

Oviedo-Joekes E, Nosyk B, Brissette S, Chettiar J, Schneeberger P, Marsh DC, Krausz M, Anis A, Schechter MT.

J Urban Health. 2008 Nov;85(6):812-25. doi: 10.1007/s11524-008-9312-9. Epub 2008 Aug 29.

17.

Polydrug use and implications for longitudinal research: ten-year trajectories for heroin, cocaine, and methamphetamine users.

Brecht ML, Huang D, Evans E, Hser YI.

Drug Alcohol Depend. 2008 Aug 1;96(3):193-201. doi: 10.1016/j.drugalcdep.2008.01.021. Epub 2008 Mar 10.

18.

Meta-analysis of depression and substance use and impairment among intravenous drug users (IDUs).

Conner KR, Pinquart M, Duberstein PR.

Addiction. 2008 Apr;103(4):524-34. doi: 10.1111/j.1360-0443.2007.02118.x. Epub 2008 Feb 4. Review.

19.

Heroin and cocaine co-use in a group of injection drug users in Montréal.

Leri F, Stewart J, Tremblay A, Bruneau J.

J Psychiatry Neurosci. 2004 Jan;29(1):40-7.

Supplemental Content

Support Center